Cancer services at the Trust are delivered through Multi-Disciplinary Teams (MDTs) bringing together Consultants, Clinical Nurse Specialists (CNS) and a range of other specialist Allied Health Professionals (AHPs) who look after patients who have or are suspected to have cancer. The MDTs are crucial to reaching the correct treatment.
The Trust has a dedicated cancer unit, working in partnership with other nearby centres to provide a wide range of services for the local population. We receive approximately 17,000 urgent cancer referrals every year. Cancer services are embedded throughout the whole of the organisation as patients are referred to different departments for investigation, diagnosis and treatment.
We care for approximately 3300 new cancer patients every year, ranging from newly diagnosed patients through to patients requiring palliative care and we provide a range of diagnostic services, including Radiology investigations (scans and X rays), Endoscopy (camera tests for bowel and upper GI cancers) and Pathology (blood tests and review of tissues to confirm or exclude cancers).
We provide surgery for some cancers (breast, colorectal, some gynaecology, skin and kidney).
Chemotherapy and supportive care treatments are provided by our:
Ward 2 A
Radiotherapy is not provided on site as this mode of treatment requires highly specialist facilities. Our patients can see an Oncologist at the Trust and then access radiotherapy through them at Clatterbridge Cancer Centre (either Wirral or Aintree site).
Cancer Research and Clinical Trials
We have a range of clinical trials that are ongoing in the hospitals and we know these are an important option for patients. If there is a trial available for your individual situation, you may be approached by your clinical team to see if you would like to take part. The trials team fully appreciate that when patients are referred for tests for cancer that they are anxious and we try to ensure they have all the relevant information they need. We are happy to be contacted for advice.